Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
ValACYclovir 1000 MG
Shingrix
Locations
1
United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Start Date
March 27, 2023
Primary Completion Date
August 1, 2026
Completion Date
August 1, 2026
Last Updated
May 16, 2025
NCT07406945
NCT04641702
NCT06883175
NCT06189859
NCT06213662
NCT02518542
Lead Sponsor
Vanderbilt University Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions